Patent Assignment
Reel/Frame 063992/0870
Assignment of Assignor's Interest
Recorded: 2023-06-15
Pages: 80
Assignor
SECURA BIO, INC.
Executed: 2022-10-31
Assignee
PHARMA& SCHWEIZ GMBH
RIEDSTRASSE 1, CHAM, 6330, SWITZERLAND
Covered Properties
(4)
Polymorphs of N-Hydroxy-3-[4-[[[2-(2-Methyl-1H-Indol-3-Yl)Ethyl]Amino]Methyl]Phenyl]-2E-2-Propenamide
Process for Making Salts of N-Hydroxy-3-[4-[[[2-(2-Methyl-1H-Indol-3-Yl)Ethyl]Amino]Methyl]Phenyl]-2E-2-Propenamide
Use of Hdac Inhibitors for the Treatment of Myeloma
Process for Making N-Hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and Starting Materials Therefor
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 8, 2011
From: BAJWA, JOGINDER; PARKER, DAVID JOHN; SLADE, JOEL
To: NOVARTIS AG
Reel/Frame 026096/0710 →
Assignment of Assignor's Interest
May 20, 2011
From: ACEMOGLU, MURAT; BAJWA, JOGINDER S.; KARPINSKI, PIOTR; PAPOUTSAKIS, DIMITRIS
To: NOVARTIS AG
Reel/Frame 026316/0103 →
Assignment of Assignor's Interest
May 24, 2013
From: ACEMOGLU, MURAT; BAJWA, JOGINDER S.; PARKER, DAVID JOHN; SLADE, JOEL
To: NOVARTIS AG
Reel/Frame 030482/0210 →
Assignment of Assignor's Interest
Aug 25, 2014
From: ATADJA, PETER W.
To: NOVARTIS AG
Reel/Frame 033602/0503 →
Assignment of Assignor's Interest
Mar 1, 2019
From: NOVARTIS PHARMA AG
To: SECURA BIO, INC.
Reel/Frame 048477/0661 →
Security Interest
Mar 5, 2019
From: SECURA BIO, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048510/0364 →
Confirmatory Assignment
May 21, 2019
From: NOVARTIS AG
To: SECURA BIO, INC.
Reel/Frame 049246/0720 →
Release of Ip Security Interest at Reel/Frame 048510/0364
Oct 31, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SECURA BIO, INC.
Reel/Frame 061814/0821 →